Akari Therapeutics Plc (AKTX) Return on equity
Akari Therapeutics Plc (AKTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-991.0%FY2022
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -991.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AKTX financial trends
AKTX RevenueAKTX Net incomeAKTX Net marginAKTX Gross profitAKTX Gross marginAKTX Operating incomeAKTX Operating marginAKTX Operating cash flowAKTX Free cash flowAKTX Capital expendituresAKTX Stock buybacksAKTX Dividends paidAKTX Total assetsAKTX Total liabilitiesAKTX Shareholders’ equityAKTX overview →